Cite Filings / XFOR / 0000902664-25-004474

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

X4 Pharmaceuticals, Inc Filed 2025-10-21 Acc 0000902664-25-004474

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-11-03 SCHEDULE 13G Statement of Beneficial Ownership
2025-10-27 4 Executive Chairman bought 86,206 shares at $2.90 ($249,997)
2025-10-27 8-K Material agreement
2025-10-24 424B5 Prospectus
2025-10-23 424B5 Prospectus
2025-10-21 SCHEDULE 13G Statement of Beneficial Ownership
2025-10-03 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…